SE9901007D0 - Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence - Google Patents

Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence

Info

Publication number
SE9901007D0
SE9901007D0 SE9901007A SE9901007A SE9901007D0 SE 9901007 D0 SE9901007 D0 SE 9901007D0 SE 9901007 A SE9901007 A SE 9901007A SE 9901007 A SE9901007 A SE 9901007A SE 9901007 D0 SE9901007 D0 SE 9901007D0
Authority
SE
Sweden
Prior art keywords
sialyl
inhibition
lewis
carbohydrate structures
fucosylated sialylated
Prior art date
Application number
SE9901007A
Other languages
English (en)
Swedish (sv)
Inventor
Thomas Boren
Lennart Hammarstroem
Karl-Anders Karlsson
Susann Teneberg
Original Assignee
Thomas Boren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Boren filed Critical Thomas Boren
Priority to SE9901007A priority Critical patent/SE9901007D0/xx
Publication of SE9901007D0 publication Critical patent/SE9901007D0/xx
Priority to PCT/SE2000/000514 priority patent/WO2000056343A1/en
Priority to DE60005164T priority patent/DE60005164D1/de
Priority to AT00921217T priority patent/ATE249227T1/de
Priority to EP00921217A priority patent/EP1169044B1/en
Priority to JP2000606247A priority patent/JP2002539266A/ja
Priority to AU41557/00A priority patent/AU4155700A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9901007A 1999-03-19 1999-03-19 Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence SE9901007D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9901007A SE9901007D0 (sv) 1999-03-19 1999-03-19 Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
PCT/SE2000/000514 WO2000056343A1 (en) 1999-03-19 2000-03-16 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
DE60005164T DE60005164D1 (de) 1999-03-19 2000-03-16 Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion
AT00921217T ATE249227T1 (de) 1999-03-19 2000-03-16 Verwendung von fucosilierten sialilierten n- acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion
EP00921217A EP1169044B1 (en) 1999-03-19 2000-03-16 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
JP2000606247A JP2002539266A (ja) 1999-03-19 2000-03-16 細菌接着を阻止するためのフコシル化シアリル化ｎ−アセチルラクトサミン炭水化物構造物の使用
AU41557/00A AU4155700A (en) 1999-03-19 2000-03-16 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901007A SE9901007D0 (sv) 1999-03-19 1999-03-19 Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence

Publications (1)

Publication Number Publication Date
SE9901007D0 true SE9901007D0 (sv) 1999-03-19

Family

ID=20414923

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901007A SE9901007D0 (sv) 1999-03-19 1999-03-19 Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence

Country Status (7)

Country Link
EP (1) EP1169044B1 (xx)
JP (1) JP2002539266A (xx)
AT (1) ATE249227T1 (xx)
AU (1) AU4155700A (xx)
DE (1) DE60005164D1 (xx)
SE (1) SE9901007D0 (xx)
WO (1) WO2000056343A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066502A1 (en) * 2001-02-21 2002-08-29 Boren Thomas Helicobacter pylori sialic acid binding adhesin, saba and saba - gene
FI20011403A (fi) * 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
US20040176320A1 (en) * 2001-06-29 2004-09-09 Jari Natunen Use of at least one glycoinhibitor substance
WO2003089450A2 (en) * 2002-04-22 2003-10-30 Recopharma Ab Fusion polypeptides and methods for inhibiting microbial adhesion
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
EP2692740A1 (en) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Glycan compositions, processes for preparing the same and their uses as a drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK76193D0 (da) * 1993-06-25 1993-06-25 Astra Ab Kulhydratderivater
AU709149B2 (en) * 1994-03-02 1999-08-19 Neose Technologies, Inc. Method for treating and inhibiting gastric and duodenal ulcers

Also Published As

Publication number Publication date
EP1169044A1 (en) 2002-01-09
EP1169044B1 (en) 2003-09-10
JP2002539266A (ja) 2002-11-19
AU4155700A (en) 2000-10-09
WO2000056343A1 (en) 2000-09-28
DE60005164D1 (de) 2003-10-16
ATE249227T1 (de) 2003-09-15

Similar Documents

Publication Publication Date Title
Kumar et al. Emerging trends of herbal care in dentistry
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
CA2460749A1 (en) Glycoconjugate vaccines for use in immune-compromised populations
EA200701519A1 (ru) Живая аттенуированная ротавирусная вакцина для перорального введения
EP3326634A3 (en) Composition for use in stimulating the intestinal flora in infants delivered by caesarean section
Stege et al. Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori
BR0009166A (pt) Vacina
UA89791C2 (ru) Пищевая композиция, которая содержит неусваиваемые олигосахариды, для лечения или профилактики инфекций респираторного тракта
Seltzer Pain in endodontics
HUP0300421A2 (hu) Kezelési eljárás ligand-immunogén konjugátumok felhasználásával
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
IL173481A0 (en) Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
SE9901007D0 (sv) Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
BR9808008A (pt) Processo para o tratamento anticoagulante e/ou antitrombótico de um ser humano ou outro paciente animal de sangue quente, usos de um oligossacarìdeo sulfatado e na fabricação de um medicamento, e, composição farmacêutica ou veterinária para tratamento anticoagulante e/ou antitrombótico.
BRPI0416376A (pt) composições para a redução da colonização bacteriana e da invasão do snc e métodos de uso destes
KR950013513A (ko) 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
MD20060037A (ro) Metodă de tratament al hepatitei virale acute C
BRPI0410374A (pt) composição farmacêutica que compreende valsartano
Ofek et al. A bright future for anti-adhesion therapy of infectious diseases
Niederman Strategies for the prevention of pneumonia
IL165486A0 (en) Method composition and kit for antigenic binding of norwalk-like viruses
BR0112035A (pt) peptìdeos antimicrobianos de novispirin
Isler Doxycycline-induced esopageal ulceration